Advanced Pneumatic Compression Device for Lymphedema

Palo Alto (17 mi)

Overseen byBarbara Murphy, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Waitlist Available

Sponsor: Tactile Medical

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial compares the effectiveness of an air pressure device (APCD) to standard treatment in reducing swelling and improving quality of life for head and neck cancer survivors. The device works by gently massaging the swollen areas to help move excess fluid out of the tissues.

Eligibility Criteria

This trial is for English-speaking adults over 18 who've finished cancer treatment with no active cancer, have head and neck lymphedema diagnosed, and experience related symptoms. It's not for those previously treated for this condition, with acute facial infections, carotid sinus hypersensitivity, recent severe carotid artery disease events or internal jugular venous thrombosis.

Treatment Details

The study compares an Advanced Pneumatic Compression Device (APCD) to Usual Care in managing lymphedema and fibrosis in survivors of head and neck cancer. Participants will be randomly assigned to either the APCD group or receive standard care treatments.

2Treatment groups

Active Control

Group I: Advanced Pneumatic Compression Device (APCD)Active Control1 Intervention

Daily self-administered treatment with the Flexitouch® Plus system (FT)

Group II: Usual CareActive Control1 Intervention

Complete Decongestive Therapy (CDT) directed by a lymphedema therapist and any additional adjunctive measures as prescribed by the lymphedema therapist